The report found 47,594 mentions of these two narcotic pain medications in 42,808 emergency room visits related to drug abuse. These drugs are marketed under many brand names, including Vicodin®, OxyContin®, and Percocet®. Approximately three-quarters of emergency room visits involving oxycodone (71 percent) and hydrocodone (78 percent) also involved additional drugs. Visits to emergency rooms involving both hydrocodone and its combinations and oxycodone and its combinations have been trending upward since 1994.

"The abuse of narcotic pain relievers is a serious and growing public health problem," SAMHSA Administrator Charles Curie noted. "Narcotic pain medications are wonders of modern medicine for patients with serious pain who are under the care of physicians. When diverted from their legitimate use, however, they are highly addictive narcotics that the body perceives exactly as if the person were taking heroin."

Of the 42,808 drug-abuse related visits to emergency rooms involving either oxycodone or hydrocodone, 3,000 involved use of both drugs simultaneously. Alcohol was present in 33 percent of emergency room visits involving oxycodone and 31 percent of visits involving hydrocodone. Benzodiazepines (anti-anxiety medications) were present with 21 percent of oxycodone visits and 26 percent of hydrocodone-involved emergency room visits. Cocaine was involved in 12 percent of oxycodone-related visits and nine percent of hydrocodone-related visits, while heroin was involved in eight percent of oxycodone-related visits and four percent of hydrocodone-related visits.

Marijuana was found in seven percent of visits involving oxycodone, and in five percent of visits to emergency rooms involving hydrocodone. Carisoprodol, which is used therapeutically as a muscle relaxant, was present in four percent of visits involving oxycodone and eight percent of visits involving hydrocodone in 2002.

DAWN measures mentions of specific illicit, prescription and over-the- counter drugs that are linked to drug abuse in visits to hospital emergency departments.

The new report is available on the internet at http://oas.samhsa.gov/2k4/oxycodone/oxycodone.cfm .

SAMHSA, a public health agency within the U.S. Department of Health and Human Services, is the lead federal agency for improving accountability, quality and effectiveness of the Nation's substance abuse prevention, addictions treatment and mental health services.